فهرست:
فصل اول: مقدمه و بیان مسأله
مقدمه................................................................... ..……………………………………......................1
1-1-1 کبد چرب غیر الکلی..................................................................................................................2
1-1-2 درمان NASH.........................................................................................................................8
1-2 بیان مسأله و اهمیت پژوهش..........................................................................................................9
1-3 اهداف و فرضیات............................................................................................................................10
1-3-1 هدف اصلی...............................................................................................................................10
1-3-2 اهداف فرعی..............................................................................................................................10
1-3-3 فرضیات پژوهش.........................................................................................................................11
فصل دوم: بررسی متون
2-1 مقدمه............................................................................................................................................13
2-2 مبانی نظری پژوهش.....................................................................................................................15
2-3 مروری بر مطالعات انجام گرفته......................................................................................................16
2-3-1 مطالعات انجام شده در ایران.....................................................................................................16
2-3-2 مطالعات انجام شده در جهان...................................................................................................20
فصل سوم: روش پژوهش
3-1 مقدمه...........................................................................................................................................26
3-2 نوع پژوهش.................................................................................................................................26
3-3 جامعه پژوهش همراه با معیارهای ورود و خروج..............................................................................26
3-4 روش نمونه گیری و حجم نمونه......................................................................................................27
3-5 روش گردآوری داده ها..................................................................................................................28
3-6 ابزار گردآوری داده ها.......................................................................................................................29
3-7 روش تجزیه و تحلیل داده ها........................................................................................................31
3-8 مکان و زمان مطالعه......................................................................................................................31
3-9 محدودیت های پژوهش.....................................................................................................................31
3-10 ملاحظات اخلاقی........................................................................................................................32
3-11 تعریف واژه ها..............................................................................................................................33
فصل چهارم: یافته ها
4- یافته ها.........................................................................................................................................36
فصل پنجم: بحث، نتیجه گیری و ارائه پیشنهادات
5-1بحث..............................................................................................................................................50
5-2 نقاط قوت وضعف ........................................................................................................................54
5-3 نتیجه گیری......................................................................................................................................55
5-4 ارائه پیشنهادات
منبع:
- Ahmadi Mahmoodabadi, N .Madani, H. Mahzouni, P. Vahdati, A.( 2007). “ Preventive effect of hydroalcoholic extract of Cynara scolymus in type I diabetes mellitus in adult male rats.“ Iranian Journal of Diabetes and Lipids. 6: 37-44. (In persian).
- Ahmadi Mahmoodabadi, N.( 2008). “The effects of hydroalcoholic extracts of dill (Anethum graveolens L.) and artichoke (Cynara scolymus L.) against type 1 diabetes mellitus. “ Iranian Journal of Medicinal and Aromatic Plants, Vol. 24, No. 3 (In persian).
- Allain, CC. Poon, LS. Chan, CS. Richmond, W.( 1974). “ Enzymztic Determination of Total Serum Cholesterol.” Clin Chem. 20:470 -75.
- Angelico, F. Burattin, M. Alessandri, C. Del Ben, M. Lirussi, F.( 2007).” Drugs improving insulin resistance for non –alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.”Cochrane Database Syst Rev.1:CD005166.
- Arion, W.J., Canfield, W.K., Ramos, F.C. and Schindler, P.W.(1997). Chlorogenic acid and hydroxyl nitrobenzaldehyde: new inhibitor of hepatic glucose 6-phosphatase. Archives of Biochemistry and Biophysics, 339(2): 315-322.
- Arun, J. Clements, RH. Lazenby, AJ. Leeth, RR. Abrams, GA. (2006). “ The prevalence of non alcoholic steatohepatitis is greater in morbidity obese men compared to women.” Obes surg 16(10):1351-8.
- Ashok, K. and Rao, J., (2002). Diabetes mellitus and multiple therapeutic of phytochemical: Present status and future prospects. Current Sciences, 83: 30-38.
- Assman, G. Jabs, HU. Kohnert, U.Nolte, W. Schriewer, H.( 1984). “ LDL-Cholesterol Determination in Blood Serum following Precipitation of LDL with Polyvinylsulfate.” Clin Chim Acta. 140:77-83.
- Azzini, E. Bugianesi, R. Romano, F. Di Venere, D. Miccadei, S. Durazzo, A. et al.(2007).” Absorption and metabolism of bioactive molecules after oral consumption of cooked edible heads of Cynara scolymus L. (Cultivar Violetto di Provenza) in human subjects: a pilot study”. Br J Nutr. 97(5): 963-9.
- Brown, MS. Goldstein, JL.(1997). “ The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of Membrane Bound Transcription Factor.” 89:331–40.
- Brunt, M. (2007). “Pathology of fathy liver disease.” Modern pathology; 20: s40-s48 1:540.
-Cetto, A.A. and Wiedenfeld, H.(2001).” Hypoglycemic effect of Cecropia obtusifolia on streptozotocondiabetes rats.” Ethnopharmacology, 78: 145-149.
-Chalasani, N. Younossi, Z. Lavine, JE. Diehl, AM. Brunt, EM. Cusi, K. et al.( 2012).” The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.” Gastroenterology 142(7):1592-609.
- C. P. Day and O. F. W. James.( 1998 ). “Steatohepatitis: a tale of two “Hits”,” Gastroenterology.114(4): 842–845.
- Caballero, F. Fernandez, A. De Lacy, AM. Fernandez-Checa, JC. Caballeria, J. (2009). “ Enhanced Free Cholesterol SREBP-2 and StAR Expression in Human NASH.” J Hepatolology. 50:789–96.
- Corrado, RL. Torres, DM. Harrison, SA.(2014). “Review of treatment options for nonalcoholic fatty liver disease.” Med Clin North Am 98(1):55-72.
-Dyson, JK. Anstee, QM. McPherson, S .(2014). ”Non-alcoholic fatty liver disease: a practical approach to treatment.”Frontline Gastroenterol 5(4):277-86.
- Fassati, P. Prencipe, L.(1982).” Serum Triglycerides Determined Colorimetrically with an Enzyme That Produces Hydrogen Peroxide.” Clin Chem. 28:2077-80.
- Fauci,Braun wald, kasper, Hauser, Longo, Jameson, Loscalzo. (2012) .principles of harrison’s internal medicine 18th edition p1811-18.
Gebhardt, R. (1998).”Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts.” J Pharmacol Exp Ther. 286(3): 122-8.
- Heebøll, S. Kazankov, K. Poulsen, MK. Vilstrup, H. Grønbæk, H.( 2012).” Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis .” Ugeskr Laeger Feb 20. 174(8):488-90.
- Heidarian, E. Rafieian-Kopaei, M. (2013). “Protective effect of artichoke (Cynara scolymus) leaf extract against lead toxicity in rat. “51(9):1104-9.
- Heidarian, E. Soofiniya, Y. Hajihosseini, R .( 2011 ). “The effect of aerial part of Cynara scolymus extract on the hyperlipidemia, plasma antioxidant capacity, and superoxide dismutase activity in diabetic rats.” Journal of Shahrekord University of Medical Sciences(J Shahrekord Univ Med Sci) Dec, Jan. 13(5): 1-10. (In persian).
- Horoszkiewicz, M. Kulza, M. Malinowska, K. Woźniak, A. Seńczuk-Przybyłowska, M. Wachowiak, A.( 2012). “ Artichoke--untapped potential of herbal medicine in the treatment of atherosclerosis and liver diseases.” Przegl Leg .69(10):1129-31.
- Huber, R. Müller, M. Naumann, J. Schenk, T. Lüdtke, R.( 2009). “ Artichoke leave extract for chronic hepatitis C - a pilot study.” Phytomedicine. 16(9):801-4.
- Jadeja, R. Devkar, RV. Nammi, S.( 2014). “ Herbal medicines for the treatment of nonalcoholic steatohepatitis: current scenario and future prospects.” Evid Based Complement Alternat Med.648308.
- Kulza, M. Adamska, K. Seńczuk-Przybyłowska,M. Woźniak, A. Wachowiak, A. Miechowicz, I et al. (2012) . “Artichoke--herbal drug.” Przegl Lek. 69(10):1122-6 .
- Lopez – Virella, MF. Stone, P. Elli, S. Golwell, JA.( 1977).” Cholesterol Determination in HDL-Chol Separated by Three Different Methods.” Clin Chem . 23:882-84.
- Ludwig, J. Viggiano, TR. McGill, DB. (1980). “Nonaalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease.” Mayo Clin Proc. 55 :434-38.
- Machado, MV. Cortez-Pinto, H.(2014).”Non-alcoholic fatty liver disease: What the clinician needs to know.” World J Gastroenterol 20(36):12956-80.
- Marchesini, G. Marzochi, R. Agostini, F. Bugianesi, E.(2005). “Nonalcoholic fatty liver disease and the metabolic syndrome.” Curr Opin lipidol 16: 421-27.
- Mehmetçik, G. Ozdemirler, G. Koçak-Toker, N. Cevikbaş, U. Uysal M. (2008). Effect of Pretreatment with Artichoke Extract on Carbon Tetrachloride Induced Liver Injury and Oxidative Stress. “ Exp Toxicol Pathol. 60:475-80.
- Metwally, NS. Kholeif, TE. Ghanem, KZ. Farrag, AR. Ammar, NM. Abdel-Hamid, AH.( 2011). “The protective effects of fish oil and artichoke on hepatocellular carcinoma in rats.” Eur Rev Med Pharmacol Sci. 15(12):1429-44.
- Miccadei, S. Di Venere, D. Cardinali, A. Romano, F. Durazzo, A. Foddai, MS. Et al . (2008). “Antioxidative and apoptotic properties of polyphenolic extracts from edible part of artichoke (Cynara scolymus L.) on cultured rat hepatocytes and on human hepatoma cells.” Nutr Cancer. 60(2):276-83.
- Mouzaki, M. Allard, J.( 2012).” Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic.” Ann Gastroenterol .25(3):207-17.
- Mulinacci, N. Prucher, D. Peruzzi, M. Romani, A. Pinelli, P. Giaccherini , C. et al.( 2004).” Commercial and laboratory extracts from artichoke leaves: estimation of cffeoyl esters and flavonoidic compounds content.” J Pharmaceutic Biomed Analys. 34:349-57.
- Narenjkar, J. Roghani, M. Sedaghat, R. and Tehami, M.( 2009). “ Evaluation of the effect of Cynara scolymus L. Feeding on Serum Glucose and Lipids in Female Diabetic Rats.” Daneshvar Medicine, Scientific-Research Journal of Shahed University Sixteenth Year, No.83 October-November. (In persian).
Nazni, P. Vijayakumar, TP. Alagianambi, P. Amirthaveni, M. (2006) .”Hypoglycemic and hypolipidemic effect of Cynara Scolymus among selected type 2 diabetic individuals.” Pakistan J Nutr. 5(2): 147-51.
- Narenjkar , J. Roghani, M. Sedaghat, R. Tahami, M.( 2010).” The effect of oral feeding of Cynara scolymus L. on thoracic aorta contractile response in diabetic rats.” Scientific-Research Journal of Shahed University Seventeenth Year, No.87 June, July. (In persian).
- Orangi, E. Ostad Rahimi, A. Mahdavi, R. Somi, M. Tarzemani, M. (2011). “Oxidative Stress-related Parameters and Antioxidant Status in Non-alcoholic Fatty Liver Disease Patients.” Iranian Journal of Endocrinology and Metabolism.Vol 12 No.5.
- Pittler, MH. Thompson, CJ. Ernst, E. (2009).”Artichoke leaf extract for treating hypercholesterolemia.” Cochrane Database Syst Rev.7 (4):CD003335.
- Qiang, Z. Lee, SO. Ye, Z. Wu, X. Hendrich, S. (2012). “ Artichoke extract lowered plasma cholesterol and increased fecal bile acids in Golden Syrian hamsters.” Phytother Res. 26(7):1048-52.
- Reitman, S. Frankel, S.(1957).” a Colorimetric Method for The Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic Transaminases.” Am J Clin Path. 28:56-63.
- Rondanelli, M. Giacosa, A. Orsini, F. Opizzi, A. Villani, S. (2011). “Appetite Control and Glycaemia Reduction in Overweight Subjects treated with a Combination of Two Highly Standardized Extracts from Phaseolus vulgaris and Cynara scolymus.” Phytother Res. Feb 10. [Epub ahead of print].
- Rondanelliو M . Opizzi, A. Faliva, M. . Sala, P. Perna, S. Riva, A. et al.( 2013). “ Metabolic Management in Overweight Subjects with Naive Impaired Fasting Glycaemia by Means of a Highly Standardized Extract From Cynara scolymus: A Double-blind, Placebo-controlled, Randomized Clinical Trial.” Phytother Res. Feb 25. [Epub ahead of print].
-Roghani-Dehkordi, F. Kamkhah, AF.( 2009). “ Artichoke leaf juice contains antihypertensive effect in patients with mild hypertension.” J Diet Suppl. 6(4):328-41.
- Sanyal, A. Chalasani, M. Kowdley, KV. (2010). “ Piogliazone, Vitamin E or Placebo for Nonalcoholic Steatohepatitis.” N Eng j med . 362:1675-1685.45.
-Safaa, M.Hanaa, A.Abdel, F.Nahila, A.Abdelaaty, S.(2013). “Cynara Scolymus for relieving on nonalcoholic steatohepatitis induced in rat “.International Journal of Pharmacy and Pharmaceutical Sciences.5(1),57-66 .
- Schutz, K. Kammerer, D. Carle, R. Schieber, A.(2004).” Identification and quantification of caffeoylquinic acids and flavonoids from artichoke (Cynara scolymus L.) heads, juice, and pomace by HPLC-DAD-ESI/MS (n).” J Agric Food Chem. 52(13): 4090-6.
-Shimoda, H. Ninomiya, K. Nishida, N. Yoshino, T. Morikawa, T. Matsuda, H. et al.(2003).” Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action.” Bioorg Med Chem Lett. 13(2): 223-8.
- Simonen, P. Kotronen, A. Hallikainen, M. Sevastianova, K. (2010). “ Cholesterol Synthesis is Increased and Absorption Decreased in Non-alcoholic Fatty Liver Disease Independent of Obesity.” Journal of Hepatology. 54:153-9.
- Sohrabpour, AA. Rezvan, H. Amini-Kafiabad, S. Dayhim, MR. Merat, S. Pourshams, A.(2010). “ Prevalence of NonalcoholicSteatohepatitis in Iran: A Population based Study.” Middle East J Dig Dis 2:14-9.
- Speroni, E. Cervellati, R. Govoni, P. Guizzardi, S. Renzulli, C. Guerra, MC.( 2003). “Efficiency of different cynara scolymus preparations liver complaints. “ J Ethnopharmacol . 86:203–11.
- Takaki, A. Kawai, D. Yamamoto, K. (2014). “Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH).” Int J Mol Sci. Apr 29;15(5):7352-79.
-Takahashi, Y. Fukusato, T.(2014).” Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.” World J Gastroenterol. 20(42):15539-15548. Review.
- Urquiaga, I. Leighton, F. (2000).’Plant polyphenol antioxidants and oxidative stress. Biol Res. 33(2): 55-64.
- Vaya, J. Aviram, M.( 2001).” Nutritional Antioxidants Mechanisms of Action, Analyses of Activities and Medical Applications.” Curr Med Chem Immunol Endocr Metab Agents. 1: 99-117.
- Veena, J. Muragundla, A. Sidgiddi, S. Subramaniam, S. (2014 ). “Non-alcoholic fatty liver disease: need for a balanced nutritional source.” Br J Nutr. 112(11):1858-72.
- Wider, B. Pittler, MH. Thompson-Coon, J. Ernst, E.( 2009 ). “ Artichoke leaf extract for treating hypercholesterolaemia. Cochrane Database Syst Rev. “ Oct 7;(4):CD0033.
- Williams, CD . Stengel, J. Asike, MI.(2011). “Prevalence of Non Alcoholic Fatty Liver Disease and Non Alcohalic Steatohepatitis Among a Largely Middle-aged Population.” Gastroentology 140(1):124-31.
- Wittemer, SM. Ploch, M. Windeck, T. Müller, SC. Drewelow, B. Derendorf, H.et al . (2005). “Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans.” Phytomedicine. Jan. 12(1-2):28-38.
- Wittemer, SM. Ploch, M. Windeck, T. Müller, SC. Drewelow, B. Derendorf, H. et al.(2005).” Bioavilability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of artichoke leaf extracts in humans.” Phytomedicine. 12(1-2): 28-38.
- Zargari, A.( 1993).” Medicinal Plants.” Tehran University Press. 2: 125-127.